DMK Pharmaceuticals Corporation
DMK Pharmaceuticals Corporation (DMKPQ) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · DMKPQ · as of Jun 8, 2026
Key Statistics
Explore DMK Pharmaceuticals Corporation Data
dmkpq stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
dmkpq competitorsDMKPQ
ADLI
AMHD
BIMI
CFRXQ
EFTRStock Performance
Full HistoryAbout DMK Pharmaceuticals Corporation
DMK Pharmaceuticals Corporation a clinical stage neuro-biotechnology company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory …
what is dmk pharmaceuticals corporation · dmkpq stock overview · dmk pharmaceuticals corporation company profile · who is dmk pharmaceuticals corporation ceo · dmkpq OTC · dmk pharmaceuticals corporation headquarters · dmk pharmaceuticals corporation business segments
About Stock Overview & Key Data
DMK Pharmaceuticals Corporation (DMKPQ) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Aug 14, 1995. As of the latest trading session, DMKPQ stock price is $0.00, with a market capitalization of $1,010. The stock has returned +907.14% over the past 12 months and +0.71% year-to-date.
In fiscal year 2022, DMK Pharmaceuticals Corporation reported revenue of $4.8M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, DMK Pharmaceuticals Corporation (DMKPQ) stock price is $0.00. The stock is traded on OTC under the ticker symbol DMKPQ. The 52-week range is $0.00 – $0.00.